China Jo-Jo Drugstores (FRA:7QL) EBIT : €-20.1 Mil (TTM As of Sep. 2023)

View and export this data going back to 2010. Start your Free Trial

What is China Jo-Jo Drugstores EBIT?

China Jo-Jo Drugstores's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2023 was €-0.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2023 was €-20.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. China Jo-Jo Drugstores's annualized ROC % for the quarter that ended in Sep. 2023 was 0.92%. China Jo-Jo Drugstores's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -6.22%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. China Jo-Jo Drugstores's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -81.25%.

China Jo-Jo Drugstores EBIT Historical Data

The historical data trend for China Jo-Jo Drugstores's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Jo-Jo Drugstores EBIT Chart

China Jo-Jo Drugstores Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT

Get a 7-Day Free Trial

-1.05

-5.20

-6.63

-1.67

-19.31

China Jo-Jo Drugstores Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBIT	Get a 7-Day Free Trial															-0.09	-1.57	-0.10	-19.23	-0.83

Competitive Comparison of China Jo-Jo Drugstores's EBIT

For the Pharmaceutical Retailers subindustry, China Jo-Jo Drugstores's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Jo-Jo Drugstores's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Jo-Jo Drugstores's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Jo-Jo Drugstores's EV-to-EBIT falls into.

China Jo-Jo Drugstores EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-20.1 Mil.

China Jo-Jo Drugstores (FRA:7QL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

China Jo-Jo Drugstores's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

	ROC % (Q: Sep. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Sep. 2023 ))	/ count )
=	0.48 * ( 1 - -4.46% )	/	( (57.508	+	51.693)	/ 2 )
=	0.501408	/	54.6005
=	0.92 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	84.967	-	29.376	-	( 17.567	-	max(0, 62.144	-	60.227	+	17.567	))
=	57.508

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	88.798	-	37.071	-	( 17.475	-	max(0, 65.388	-	65.422	+	17.475	))
=	51.693

Note: The Operating Income data used here is two times the semi-annual (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

China Jo-Jo Drugstores's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Sep. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-1.658	/	( ( (17.77 + max(10.068, 0))	+	(17.2 + max(8.246, 0)) )	/	2 )
=	-1.658	/	( ( 27.838	+	25.446 )	/	2 )
=	-1.658	/	26.642
=	-6.22 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(13.168	+	14.299	+	12.628)	-	(29.376	+	0.65	+	0.0010000000000048)
=	10.068

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(16.41	+	18.357	+	11.164)	-	(37.071	+	0.614	+	0)
=	8.246

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

China Jo-Jo Drugstores's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2023 )
	=	-20.054	/	24.683
	=	-81.25 %

China Jo-Jo Drugstores EBIT Related Terms

Thank you for viewing the detailed overview of China Jo-Jo Drugstores's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

China Jo-Jo Drugstores (FRA:7QL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Jo-Jo Drugstores Inc (FRA:7QL) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

CJJD:USA

Address

386 Shangtang Road, Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Zhejiang Province, Hangzhou, CHN, 310008

Website

http://www.jiuzhou360.com

China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, Drug wholesale, and Herb farming. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.

China Jo-Jo Drugstores (FRA:7QL) Headlines

No Headlines